Literature DB >> 11712090

Infectious disease consultation and microbiologic surveillance for intensive care unit trauma patients: a pilot study.

B C Fox1, P B Imrey, M B Voights, S Norwood.   

Abstract

Infection remains a major cause of posttrauma morbidity. We retrospectively reviewed 2 cohorts of trauma patients admitted to a regional trauma center before and after a policy change integrating prospective microbiologic surveillance and infectious disease (ID) consultation into management of trauma admissions. Primary interests were effects of this policy change on antimicrobial use and diagnostic precision (particularly differentiation of infection from colonization). Associated costs, microflora, survival, and disability were also compared. Patients were stratified for risk of infection. ID consultation was associated with a 49% increased odds that an infection diagnosis was microbiologically based (P=.006) and 57% reduction of antibiotics costs per hospitalized day (P=.0008). Costs of consultation and an 86% increase (P<10(-6)) in total cultures combined to minimally exceed that financial saving. The observed improvements in diagnostic precision and antimicrobial usage, however, suggest consideration of prospective microbiologic surveillance and multidisciplinary physician teams including ID physicians for high-risk trauma patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11712090     DOI: 10.1086/324083

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  10 in total

1.  Cost of infectious diseases.

Authors:  C Ruef
Journal:  Infection       Date:  2002-04       Impact factor: 3.553

Review 2.  Infectious diseases consultations can make the difference: a brief review and a plea for more infectious diseases specialists in Germany.

Authors:  Siegbert Rieg; Marc Fabian Küpper
Journal:  Infection       Date:  2016-02-23       Impact factor: 3.553

Review 3.  Critical Care Medicine and Infectious Diseases: An Emerging Combined Subspecialty in the United States.

Authors:  Sameer S Kadri; Chanu Rhee; Gregory S Fortna; Naomi P O'Grady
Journal:  Clin Infect Dis       Date:  2015-05-05       Impact factor: 9.079

Review 4.  Antibiotic stewardship programmes in intensive care units: Why, how, and where are they leading us.

Authors:  Yu-Zhi Zhang; Suveer Singh
Journal:  World J Crit Care Med       Date:  2015-02-04

5.  Formal infectious diseases consultation is associated with decreased mortality in Staphylococcus aureus bacteraemia.

Authors:  J O Robinson; S Pozzi-Langhi; M Phillips; J C Pearson; K J Christiansen; G W Coombs; R J Murray
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-03       Impact factor: 3.267

6.  Infectious disease services: a survey from four university hospitals in Germany.

Authors:  Siegbert Rieg; Florian Hitzenbichler; Stefan Hagel; Isabelle Suarez; Florian Kron; Bernd Salzberger; Mathias Pletz; Winfried V Kern; Gerd Fätkenheuer; Norma Jung
Journal:  Infection       Date:  2018-08-17       Impact factor: 3.553

7.  Prospective study of telephone calls to a hotline for infectious disease consultation: analysis of 7,863 solicited consultations over a 1-year period.

Authors:  S Gennai; P François; E Sellier; J-P Vittoz; V Hincky-Vitrat; P Pavese
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-11-11       Impact factor: 3.267

8.  Infectious diseases consultation lowers mortality from Staphylococcus aureus bacteremia.

Authors:  Timothy Lahey; Ruta Shah; Jennifer Gittzus; Joseph Schwartzman; Kathryn Kirkland
Journal:  Medicine (Baltimore)       Date:  2009-09       Impact factor: 1.889

9.  Contribution of antimicrobial stewardship programs to reduction of antimicrobial therapy costs in community hospital with 429 Beds --before-after comparative two-year trial in Japan.

Authors:  Tetsuya Fukuda; Hidemi Watanabe; Saeko Ido; Makoto Shiragami
Journal:  J Pharm Policy Pract       Date:  2014-08-05

10.  The Value That Infectious Diseases Physicians Bring to the Healthcare System.

Authors:  Daniel P McQuillen; Ann T MacIntyre
Journal:  J Infect Dis       Date:  2017-09-15       Impact factor: 5.226

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.